Stratrix
Competitors · Steris

Who are Steris’s competitors?

Steris names 21 companies as competitors in its latest annual report, on 4 fronts.

Skip to the field, head to head ↓Steris company profile

Competitors it names2110-K for fiscal 2026
Companies that name it0in their own annual reports
Revenue, FY to Mar 2026$5.9B+9% on a year
Net margin13%Ecolab 13% · Stryker 13%
Stratrix’s Take

Steris names 21 rivals across four lists, and none appears on all four

Steris sorts its competitors into four groups: products, services, sterilization and infection prevention, and contract sterilization. The groups barely overlap. Belimed, Ecolab and Getinge appear in two. So does Olympus. No one appears in three. Contract sterilization names Sterigenics alone.

So the only name on every list is Steris. Each rival meets it on one front or two, while Steris meets all of them. The rivals also look unlike one another. Stryker reported revenue of $25.1 billion and Fortive $4.2 billion. Ecolab paid $1.6 billion in cash for Ovivo's electronics business. Boston Scientific bought Apollo Endosurgery and Relievant Medsystems. Their money is going in different directions.

Steris brought in $5.9 billion, grew 9% and kept a 13% net margin. The idea to repeat: Steris's position is its breadth. Each rival contests a piece of it, and Steris has to defend the whole.

The fronts

Where Steris says it competes

Product-based competitors
3MBaxterBoston ScientificBelimedEcolabFortiveGetingeKarl StorzOlympusRuhofSteelCoStrykerSkytronWassenburg
“On a product basis, competitors include 3M, Baxter, Boston Scientific, Belimed, Ecolab, Fortive, Getinge, Karl Storz, Olympus, Ruhof, SteelCo, Stryker, Skytron and Wassenburg.”
In its own words · 10-K for fiscal 2026
Service line competitors
BBraunCrothallOlympusPentax
“competitors include BBraun, Crothall, Olympus and Pentax”
In its own words · 10-K for fiscal 2026
Competitors in sterilization and infection prevention
BelimedContecEcolabFedegariGetingeStilmas
“Competitors include Belimed, Contec, Ecolab, Fedegari, Getinge, and Stilmas.”
In its own words · 10-K for fiscal 2026
Contract sterilization competitors
Sterigenics
“competes with Sterigenics, other smaller contract sterilization companies”
In its own words · 10-K for fiscal 2026
Head to head

The field, from the filings

CompanyFiscal yearRevenueGrowthNet marginEmployees
SterisFY to Mar 2026$5.9B+9%13%18,000
Stryker2025$25.1B+11%13%56,000
3M2025$24.9B+2%13%–
Boston Scientific2025$20.1B+20%14%59,000
Ecolab2025$16.1B+2%13%–
Baxter International2025$11.2B+6%−9%–
Fortive2025$4.2B+2%14%–

Each company’s latest fiscal year as reported to the SEC, in US dollars; fiscal years end in different months. Rivals that report outside the US or in other currencies are not shown.

The moves

What the rivals have done lately

StrykerAcquired Cerus Endovascular

“On May 2, 2023 we acquired Cerus for net cash consideration of $ 289 and up to $ 225 in future milestone payments that had a fair value of $ 192 at the acquisition date.” filing

Boston ScientificAcquired Apollo Endosurgery

“In the second quarter of 2023, we completed the acquisition of Apollo Endosurgery, Inc., a public company that has developed and commercialized endoscopic suturing devices including OverStitch™ Endoscopic Suturing Systems and X-Tack™ End…” filing

Boston ScientificAcquired Relievant Medsystems

“In addition, in the fourth quarter of 2023, we completed the acquisition of Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept™ Intraosseous Nerve Ablation System, …” filing

EcolabAcquired Ovivo's electronics business

“On December 16, 2025, we acquired Ovivo’s electronics business (“Ovivo Electronics”) for total consideration of $1.6 billion in cash.” filing

Baxter InternationalAcquired Zosyn rights from a subsidiary of Pfizer

“Under the terms of the acquisition, we paid the acquisition price of $122 million and received specified intellectual property, including patent rights, in the first quarter of 2022 and received additional intellectual property, includin…” filing

Questions

Asked about Steris’s competitors

Who are Steris's competitors?

In its annual report for fiscal 2026, Steris names 21 competitors across 4 fronts: product-based competitors, service line competitors, competitors in sterilization and infection prevention and contract sterilization competitors. 10-K for fiscal 2026

How does Steris compare with its rivals?

Steris reported $5.9B in revenue in its latest fiscal year, +9% on a year, with a 13% net margin. Ecolab: $16.1B, 13% net margin; Stryker: $25.1B, 13% net margin.

What are the alternatives to Steris?

The companies Steris itself names as competitors are listed above, front by front, each in its own report’s words. Which matters for a given buyer depends on the job, not the list.

What would it cost a challenger to take your customer?

What would it actually cost a challenger to take your customer?

See the pack →

Sources: Steris’s annual report for fiscal 2026; the annual reports of the companies that name it; each company’s financial data as reported to the SEC; Stratrix Decision Records. Analysis and data, not advice.

For information and strategic analysis only, not investment advice. Stratrix does not recommend buying, selling or holding any security.

Tools to try

More from Stratrix

The Moat Anatomy Casebook

Every verified case of this decision, with what was on the table and how it turned out, in Excel, PowerPoint, Word and PDF.

35 verified cases · $299See the casebook →

The Business Model Wizard

Make the seven choices that define your model, test your numbers against real companies, and meet the rival AI would build against you.

Free · about twelve minutesBuild your Model Thesis →

Weekly email

Stratonomics, every Tuesday

One data story every Tuesday: what happened, what it means, and the figures you can quote. Free.

We'll email you a link to confirm. Unsubscribe anytime. Privacy policy.